Short-term serial circulating tumor DNA assessment predicts therapeutic efficacy for patients with a...
Short-term serial circulating tumor DNA assessment predicts therapeutic efficacy for patients with advanced pancreatic cancer
About this item
Full title
Author / Creator
Motobayashi, Hideki , Kitahata, Yuji , Okada, Ken-ichi , Miyazawa, Motoki , Ueno, Masaki , Hayami, Shinya , Miyamoto, Atsushi , Shimizu, Atsushi , Sato, Masatoshi , Yoshimura, Tomohiro , Nakamura, Yuki , Takemoto, Norio , Nakai, Tomoki , Hyo, Takahiko , Matsumoto, Kyohei , Yamaue, Hiroki and Kawai, Manabu
Publisher
Berlin/Heidelberg: Springer Berlin Heidelberg
Journal title
Language
English
Formats
Publication information
Publisher
Berlin/Heidelberg: Springer Berlin Heidelberg
Subjects
More information
Scope and Contents
Contents
Purpose
We investigated the potential clinical utility of short-term serial
KRAS
-mutated circulating cell-free tumor DNA (ctDNA) assessment for predicting therapeutic response in patients undergoing first-line chemotherapy for advanced pancreatic cancer.
Methods
We collected 144 blood samples from 18 patients with locally advanced o...
Alternative Titles
Full title
Short-term serial circulating tumor DNA assessment predicts therapeutic efficacy for patients with advanced pancreatic cancer
Authors, Artists and Contributors
Identifiers
Primary Identifiers
Record Identifier
TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_10817839
Permalink
https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_10817839
Other Identifiers
ISSN
1432-1335,0171-5216
E-ISSN
1432-1335
DOI
10.1007/s00432-023-05594-1
